Nicotinamide protects target cells from cell-mediated cytolysis
- 31 May 1988
- journal article
- Published by Elsevier BV in Cellular Immunology
- Vol. 113 (2), 414-422
- https://doi.org/10.1016/0008-8749(88)90038-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Evidence for three types of human cytotoxic lymphocyteImmunology Today, 1986
- Polymorphic radiation sensitivity of human natural killer activity: Possible role of DNA strand breakageHuman Immunology, 1985
- Similar sensitivity of human lymphoblast cells proficient or deficient in nucleotide biosynthesis to the cytotoxic and cell cycle effects of 3-aminobenzamideExperimental Cell Research, 1985
- Nicotinamide prevents the development of cyclophosphamideinduced diabetes mellitus in male non-obese diabetic (NOD) mice Biomedical Research, 1985
- Inhibitors of Poly(Adenosine Diphosphate-Ribose) Synthesis: Effect on Other Metabolic ProcessesScience, 1984
- Preventive and Therapeutic Effects of Large-Dose Nicotinamide Injections on Diabetes Associated with Insulitis: An Observation in Nonobese Diabetic (NOD) MiceDiabetes, 1982
- Amplification of pyridine nucleotide pools in mitogen-stimulated human lymphocytesExperimental Cell Research, 1982
- Effect of nicotinamide on RNA and DNA synthesis and on poly(ADP‐ribose) polymerase activity in normal and phytohemagglutinin stimulated human lymphocytesFEBS Letters, 1980
- Association of Poly(Adenosine Diphosphoribose) Synthesis with DNA Damage and Repair in Normal Human LymphocytesJCI Insight, 1979
- The lethal hit stage of mouse T and non‐T cell‐mediated cytolysis: differences in cation requirements and characterization of an analytical “cation pulse” methodEuropean Journal of Immunology, 1976